Industry litigation – Page 3
-
BusinessArkema settles local claims over US hurricane fire emissions
Peroxides producer will pay $1.1 million and make safety improvements
-
BusinessExplainer: How is the US pharmaceutical patent system being misused?
What are ‘evergreening’ and ‘thicketing’ and what is being done to reform the system and aid competition?
-
BusinessUS Supreme Court quashes Purdue opioid bankruptcy plan
Ruling says deal cannot grant Sackler family owners protection from prosecution
-
BusinessVent and burn in East Palestine train derailment was unnecessary
Safety board investigation confirms faulty wheel bearing caused crash
-
BusinessRail company will pay $600 million to settle East Palestine lawsuits
Norfolk Southern reaches agreement to resolve litigation related to last year’s train derailment that spilled hazardous chemical cargo
-
Business$6.6 million settlement follows 2019 fire at Texas petrochemical facility
Site owner to pay compensation for environmental damage caused by release of hazardous chemicals during days-long fire
-
Business3M finalises PFAS settlement with US water suppliers
Court-approved scheme will see up to $12.5 billion to fund cleanup of public drinking water systems
-
BusinessChemours suspends chief and senior executives over accounting issues
Auditors to investigate issues around whistleblowing and financial management
-
OpinionMaking chemicals safe and sustainable
The green transition is an opportunity to also make industry simpler and safer
-
BusinessUS federal court revokes approval of dicamba herbicides
Judge overturns 2020 reapproval of three products over procedural failure
-
NewsTrihalomethane levels in Irish drinking water too high, European court rules
Long-term exposure could pose risks to human health and the environment
-
BusinessMonsanto must pay $857 million over PCB exposure at a Washington school
US jury orders Bayer subsidiary to compensate seven people who claim to have been sickened by chemicals leaking from a school’s light fixtures
-
BusinessIllumina to give up Grail as competition appeals fail
Sequencing giant will sell off its former spin-out in accordance with regulator orders
-
BusinessChemicals roundup 2023
Chemical companies entered cost-cutting mode in a year dominated by overcapacity and slow demand
-
BusinessPharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
-
OpinionCompounding problems
Regulating the line between a vital service and grey-market profiteering is a mess
-
-
BusinessWeight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
BusinessUK Reach costs set to be slashed under government proposal
Industry may need less hazard data to register chemicals under the regime
-
BusinessThree US juries side with cancer victims over Bayer on Roundup
Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal